Home › Funds › CAPSTONE INVESTMENT ADVISORS, LLC › RGEN

CAPSTONE INVESTMENT ADVISORS, LLC position in RGEN

REPLIGEN CORP · Health Care

CAPSTONE INVESTMENT ADVISORS, LLC reported holding 33,460,000 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$39.1M, representing 0.39% of its reported portfolio and ranking #39 among its reported holdings. CAPSTONE INVESTMENT ADVISORS, LLC has disclosed RGEN holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)33.46M sh
Reported value held$39.11M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How CAPSTONE INVESTMENT ADVISORS, LLC's RGEN position evolved

CAPSTONE INVESTMENT ADVISORS, LLC first disclosed a stake in RGEN in Q3 2023 at 14,305,000 shares (US$20.5M). The position peaked in Q3 2026 at 33,460,000 shares, worth US$39.1M. Across 7 filings, CAPSTONE INVESTMENT ADVISORS, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 33,460,000 shares valued at US$39.1M — an increase of 10,960,000 shares quarter over quarter.. Notable position changes include a 100% trim in Q1 2024 (shares fell 31% over the following quarter), a 748652% increase in Q2 2026 (shares rose 41% over the following quarter), a 49% increase in Q3 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 14.30M $20.47M New
Q4 2023 12.36M $13.86M Reduce
Q1 2024 1.83K $336.76K Reduce
Q3 2025 4.71K $629.72K New
Q1 2026 3.00K $354.05K New
Q2 2026 22.50M $23.13M Add
Q3 2026 33.46M $39.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 35 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has CAPSTONE INVESTMENT ADVISORS, LLC held RGEN?

CAPSTONE INVESTMENT ADVISORS, LLC has disclosed RGEN holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

What is CAPSTONE INVESTMENT ADVISORS, LLC's current position in RGEN?

As of Q3 2026, CAPSTONE INVESTMENT ADVISORS, LLC holds 33.46M shares of RGEN (REPLIGEN CORP), valued at $39.11M, representing 0.39% of its reported portfolio and ranking #39.

Has CAPSTONE INVESTMENT ADVISORS, LLC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), CAPSTONE INVESTMENT ADVISORS, LLC increased its position in RGEN. The position peaked in Q3 2026 at 33.46M shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.